127 related articles for article (PubMed ID: 2411907)
1. Potentiation of antitumor effect of bleomycin by lipid-surfactant mixed micelles. I. In vivo and tumor-neutralizing activity against mouse Ehrlich ascites tumor and rat ascites hepatoma AH66.
Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1985 Apr; 8(4):305-10. PubMed ID: 2411907
[TBL] [Abstract][Full Text] [Related]
2. Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.
Takada K; Shibata N; Yoshimura H; Masuda Y; Yoshikawa H; Muranishi S; Oka T
J Pharmacobiodyn; 1985 Apr; 8(4):320-3. PubMed ID: 4032221
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of antitumor activity of bleomycin towards solid tumors in mice by Bacillus thuringiensis subsp. israelensis toxin.
Yokoyama Y; Ohmori I; Kohda K; Kawazoe Y
Anticancer Res; 1991; 11(4):1625-8. PubMed ID: 1720939
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
Allen TE; Aliano NA; Cowan RJ; Grigg GW; Hart NK; Lamberton JA; Lane A
Cancer Res; 1985 Jun; 45(6):2516-21. PubMed ID: 2580623
[TBL] [Abstract][Full Text] [Related]
5. The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
Kaya G; Akin C; Altuğ T; Devrim S
Proc Soc Exp Biol Med; 1988 Mar; 187(3):292-5. PubMed ID: 2450356
[TBL] [Abstract][Full Text] [Related]
6. The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles. I.
Masuda Y; Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1986 Oct; 9(10):793-8. PubMed ID: 3820056
[TBL] [Abstract][Full Text] [Related]
7. [Studies on antitumor activities and pulmonary toxicity of pepleomycin sulfate (NK631) (author's transl)].
Ebihara K; Ekimoto H; Itchoda Y; Abe F; Inoue H; Aoyagi S; Yamashita T; Koyu A; Takahashi K; Yoshioka O; Matsuda A
Jpn J Antibiot; 1978 Dec; 31(12):872-85. PubMed ID: 83410
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibition effects of oleic acid, linoleic acid, and their methyl esters on transplanted tumors in mice.
Zhu YP; Su ZW; Li CH
J Natl Cancer Inst; 1989 Sep; 81(17):1302-6. PubMed ID: 2769782
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
[TBL] [Abstract][Full Text] [Related]
10. The potentiation of the antitumor activity but not toxicity of bleomycin by 3-aminobenzamide.
Pan QC; Guo HY
J Antibiot (Tokyo); 1989 Dec; 42(12):1860-8. PubMed ID: 2482841
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral effect of bleomycin+dolomite combination treatment, in mice bearing Ehrlich ascites carcinoma.
Scheller S; Krol W; Skirmuntt K; Zydowicz G; Shani J
Z Naturforsch C J Biosci; 1993; 48(9-10):818-20. PubMed ID: 7504493
[TBL] [Abstract][Full Text] [Related]
12. Pimaricin potentiation of bleomycin activity against murine tumors.
Komiyama K; Umezawa I; Kuwano M; Komiyama S
Gan; 1983 Aug; 74(4):602-6. PubMed ID: 6195041
[TBL] [Abstract][Full Text] [Related]
13. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
14. Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin.
Su ZQ; Liu YH; Guo HZ; Sun CY; Xie JH; Li YC; Chen JN; Lai XP; Su ZR; Chen HM
Int Immunopharmacol; 2017 May; 46():146-155. PubMed ID: 28284148
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antitumor activity of bleomycin by benzamide in vitro and in vivo.
Sakamoto H; Kawamitsu H; Miwa M; Terada M; Sugimura T
J Antibiot (Tokyo); 1983 Mar; 36(3):296-300. PubMed ID: 6187722
[TBL] [Abstract][Full Text] [Related]
16. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
17. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
Nagatsu M; Richart RM; Lambert A
Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
[No Abstract] [Full Text] [Related]
18. [Antitumor effect of bestatin combined with bleomycin against hepatoma AH 66 subcutaneously transplanted in rats].
Abe F; Yamashita T; Takahashi K; Matsuda A; Ichikawa T; Umezawa H
Jpn J Antibiot; 1984 Apr; 37(4):589-92. PubMed ID: 6206250
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of a new antibiotic, neothramycin.
Hisamatsu T; Uchida S; Takeuchi T; Ishizuka M; Umezawa H
Gan; 1980 Jun; 71(3):308-12. PubMed ID: 7418976
[TBL] [Abstract][Full Text] [Related]
20. Tallysomycin S10b: experimental antitumor activity and toxicity.
Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
